Escherich, C. S., Li, Z., Barnett, K. R., Li, Y., Walker, M., Yoshimura, S., Yang, W., Huang, X., Yu, J., Stock, W., Paietta, E., Konopleva, M. Y., Kornblau, S. M., Jabbour, E., Litzow, M. R., Inaba, H., Pui, C., Loh, M. L., Evans, W. E., Savic, D., Yang, J. J. (2025). Differentiation-dependent EBF1 activity determines <i>CD22</i> transcription and leukemia sensitivity to inotuzumab ozogamicin. Blood. https://doi.org/10.1182/blood.2024028215